Long-Term Liabilities: The sum of all non-current liabilities.
Revolution Medicines, Inc. (RVMD) had Long-Term Liabilities of $432.79M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-1.13B |
|
-- |
|
-- |
|
$1.18B |
|
$-1.18B |
|
$51.07M |
|
$-1.13B |
|
$-1.13B |
|
$-1.13B |
|
$-1.13B |
|
$-1.13B |
|
$-1.13B |
|
$-1.18B |
|
$-1.19B |
|
190.13M |
|
190.13M |
|
$-5.95 |
|
$-5.95 |
|
| Balance Sheet Financials | |
$2.08B |
|
$33.19M |
|
$279.47M |
|
$2.35B |
|
$290.42M |
|
$268.45M |
|
|
Long-Term Liabilities |
$432.79M |
$723.21M |
|
$1.63B |
|
$1.56B |
|
$1.63B |
|
197.00M |
|
| Cash Flow Statement Financials | |
$-897.74M |
|
$118.06M |
|
$621.52M |
|
$546.76M |
|
$388.60M |
|
$-158.16M |
|
$118.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.14 |
|
-- |
|
-- |
|
0.14 |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-913.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.35% |
|
-72.48% |
|
-48.05% |
|
-59.55% |
|
$8.28 |
|
$-4.81 |
|
$-4.72 |
|